Study S001899

Impact of Intravenous Exenatide Versus Insulin on Quality of Life in Cardiac Surgery Patients: an Ancillary Study of the ExSTRESS Phase II/III Clinical Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02432976
Acronym: ExeQOL
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2; PHASE3
Masking: NONE
Status: COMPLETED
Enrollment: 64
Start: 2015-05
Primary completion: 2017-01
Lead sponsor: Centre Hospitalier Universitaire de Besancon
Conditions: Quality of Life
Interventions: DRUG:Exenatide; DRUG:Insulin
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Variation of the SF-36 score value at 3-months [3 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.